Thomas Jefferson University Thomas Jefferson University Jefferson Digital Commons Jefferson Digital Commons Center for Translational Medicine Faculty Papers Center for Translational Medicine 12-1-2017 HMGCS2 is a key ketogenic enzyme potentially involved in type 1 HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk. diabetes with high cardiovascular risk. Sanket Kumar Shukla Thomas Jefferson University Weijing Liu Shanghai Tenth People's Hospital Kunal Sikder Thomas Jefferson University Sankar Addya Thomas Jefferson University Amrita Sarkar Thomas Jefferson University See next page for additional authors Follow this and additional works at: https://jdc.jefferson.edu/transmedfp Part of the Cardiology Commons, and the Translational Medical Research Commons Let us know how access to this document benefts you Recommended Citation Recommended Citation Shukla, Sanket Kumar; Liu, Weijing; Sikder, Kunal; Addya, Sankar; Sarkar, Amrita; Wei, Yidong; and Rafq, Khadija, "HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk." (2017). Center for Translational Medicine Faculty Papers. Paper 42. https://jdc.jefferson.edu/transmedfp/42 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Center for Translational Medicine Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.